Total Payments
$2,867
2023 Payments
$25.00
Companies
12
Transactions
59
Medicare Patients
235
Medicare Billing
$23,554
Payment Breakdown by Category
Food & Beverage$2,836 (98.9%)
Gifts$19.50 (0.7%)
Education$11.62 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,836 | 55 | 98.9% |
| Gift | $19.50 | 1 | 0.7% |
| Education | $11.62 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $996.27 | 14 | $0 (2022) |
| GlaxoSmithKline, LLC. | $617.17 | 14 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $509.34 | 14 | $0 (2021) |
| Genentech USA, Inc. | $265.71 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $137.17 | 2 | $0 (2019) |
| Edwards Lifesciences Corporation | $114.38 | 4 | $0 (2022) |
| PFIZER INC. | $98.63 | 1 | $0 (2018) |
| EISAI INC. | $37.48 | 2 | $0 (2022) |
| GENZYME CORPORATION | $25.00 | 1 | $0 (2023) |
| Lilly USA, LLC | $24.71 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $25.00 | 1 | GENZYME CORPORATION ($25.00) |
| 2022 | $406.46 | 9 | AstraZeneca Pharmaceuticals LP ($241.09) |
| 2021 | $274.18 | 8 | AstraZeneca Pharmaceuticals LP ($137.60) |
| 2020 | $35.89 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($35.89) |
| 2019 | $697.99 | 14 | AstraZeneca Pharmaceuticals LP ($257.55) |
| 2018 | $847.81 | 17 | GlaxoSmithKline, LLC. ($322.80) |
| 2017 | $579.43 | 8 | AstraZeneca Pharmaceuticals LP ($360.03) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 11/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Respiratory | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Oncology | ||||||
| 05/09/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.53 | General |
| Category: Oncology | ||||||
| 04/26/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Respiratory | ||||||
| 04/07/2022 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $43.03 | General |
| Category: Hemodynamic Monitoring | ||||||
| 03/30/2022 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Hemodynamic Monitoring | ||||||
| 02/08/2022 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Hemodynamic Monitoring | ||||||
| 01/27/2022 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Hemodynamic Monitoring | ||||||
| 10/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/17/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Oncology | ||||||
| 09/13/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: RESPIRATORY | ||||||
| 04/21/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $86.09 | General |
| Category: Oncology | ||||||
| 03/28/2021 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Gift | Cash or cash equivalent | $19.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/01/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), TAGRISSO, FASENRA | Food and Beverage | In-kind items and services | $51.51 | General |
| Category: Respiratory | ||||||
| 09/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: RESPIRATORY | ||||||
| 02/24/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $49.03 | General |
| 09/16/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2019 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2019 | AstraZeneca Pharmaceuticals LP | DALIRESP (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Respiratory | ||||||
| 07/02/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 65 | 95 | $7,838 | $5,938 |
| 2022 | 3 | 60 | 101 | $7,174 | $5,267 |
| 2021 | 3 | 58 | 100 | $7,586 | $5,731 |
| 2020 | 3 | 52 | 105 | $9,013 | $6,618 |
Total Patients
235
Total Services
401
Medicare Billing
$23,554
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 37 | $4,749 | $3,518 | 74.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $1,841 | $1,444 | 78.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 18 | 20 | $780.57 | $610.79 | 78.2% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 18 | 27 | $467.07 | $365.69 | 78.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 44 | $5,728 | $4,195 | 73.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 19 | 20 | $800.80 | $598.65 | 74.8% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 20 | 37 | $644.91 | $472.96 | 73.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 46 | $6,052 | $4,583 | 75.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 19 | 20 | $948.20 | $706.94 | 74.6% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2021 | 18 | 34 | $586.02 | $440.96 | 75.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 41 | $4,357 | $3,462 | 79.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 38 | $4,211 | $2,825 | 67.1% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2020 | 15 | 26 | $444.34 | $330.47 | 74.4% |
About Dr. Carlos Robles, M.D
Dr. Carlos Robles, M.D is a Internal Medicine healthcare provider based in Dorado, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710148325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlos Robles, M.D has received a total of $2,867 in payments from pharmaceutical and medical device companies, with $25.00 received in 2023. These payments were reported across 59 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,836).
As a Medicare-enrolled provider, Robles has provided services to 235 Medicare beneficiaries, totaling 401 services with total Medicare billing of $23,554. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Dorado, PR
- Active Since 06/17/2008
- Last Updated 11/10/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710148325
Products in Payments
- TRELEGY ELLIPTA (Drug) $292.14
- BEVESPI AEROSPHERE (Drug) $246.32
- TAGRISSO (Drug) $198.59
- STIOLTO RESPIMAT (Drug) $193.94
- BREZTRI (Drug) $164.01
- SYMBICORT (Drug) $138.00
- ELIQUIS (Drug) $137.17
- Esbriet (Biological) $134.39
- NUCALA (Biological) $125.00
- DALIRESP (Drug) $120.00
- HemoSphere (Device) $114.38
- FASENRA (Drug) $111.81
- ANORO ELLIPTA (Drug) $99.94
- PREVNAR 13 (Biological) $98.63
- OFEV (Drug) $86.67
- ANORO (Drug) $60.00
- BREO (Drug) $37.58
- Lenvima (Drug) $37.48
- SPIRIVA (Drug) $26.01
- DUPIXENT (Biological) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dorado
Dr. Angel Vinuela, M.d, M.D
Internal Medicine — Payments: $200,290
Internal Medicine $200,290
Samayra Miranda Rodriguez, M. D, M. D
Internal Medicine — Payments: $5,412
Internal Medicine $5,412
Oswaldo De Varona Vega, Md, MD
Internal Medicine — Payments: $4,239
Internal Medicine $4,239
Raul Melendez Ayala
Internal Medicine — Payments: $3,182
Internal Medicine $3,182
Javier Tirado Manzano, Md, MD
Internal Medicine — Payments: $2,829
Internal Medicine $2,829
Dr. Samah Shehadeh, M.d, M.D
Internal Medicine — Payments: $1,437
Internal Medicine $1,437